Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer

Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer

Objectives: To explore whether Heberprot-P (an epidermal growth factor) is a cost-effective option for the treatment of advanced diabetic foot ulcer as an add-on therapy to good wound care (GWC) in Slovakia from the perspective of health care payers.Methods: A Markov model was constructed to compare...

Full description

Bibliographic Details
Main Authors: Tomas Tesar, Laszlo Szilberhorn, Bertalan Nemeth, Balazs Nagy, Martin Wawruch, Zoltan Kalo
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-12-01
Series:Frontiers in Pharmacology
Subjects:
decision making
insurance
health
health policy
Slovakia
reimbursement mechanisms
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00946/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00946/full

Similar Items